Barely Significant
← all excerpts

Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology.

Front Pharmacol · 2022 · PMC9493050 · PMID 36160448

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Compared to the control group, patients in the CaD group showed a trend of improvement in numerous indices, including glomerular filtering performance, endothelium function, and inflammatory function.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.